DK1401424T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser - Google Patents

Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser

Info

Publication number
DK1401424T3
DK1401424T3 DK02707927T DK02707927T DK1401424T3 DK 1401424 T3 DK1401424 T3 DK 1401424T3 DK 02707927 T DK02707927 T DK 02707927T DK 02707927 T DK02707927 T DK 02707927T DK 1401424 T3 DK1401424 T3 DK 1401424T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
psychotic disorders
carbamate compounds
carbamate
Prior art date
Application number
DK02707927T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1401424T3 publication Critical patent/DK1401424T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02707927T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser DK1401424T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
DK1401424T3 true DK1401424T3 (da) 2007-02-26

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02707927T DK1401424T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser

Country Status (25)

Country Link
US (1) US6541513B2 (ja)
EP (1) EP1401424B1 (ja)
JP (1) JP4276841B2 (ja)
KR (1) KR100886578B1 (ja)
CN (1) CN1262271C (ja)
AR (1) AR032876A1 (ja)
AT (1) ATE346597T1 (ja)
AU (1) AU2002242296B2 (ja)
BR (1) BR0207829A (ja)
CA (1) CA2439480C (ja)
CZ (1) CZ302412B6 (ja)
DE (1) DE60216457T2 (ja)
DK (1) DK1401424T3 (ja)
ES (1) ES2275844T3 (ja)
HU (1) HUP0303342A3 (ja)
IL (2) IL157588A0 (ja)
MX (1) MXPA03007722A (ja)
NO (1) NO20033801L (ja)
NZ (1) NZ527991A (ja)
PL (1) PL365021A1 (ja)
PT (1) PT1401424E (ja)
RS (1) RS51056B (ja)
RU (1) RU2302240C2 (ja)
TW (1) TWI251486B (ja)
WO (1) WO2002067927A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003445A3 (cs) * 2000-07-21 2004-08-18 Ortho@Mcneilápharmaceuticalźáinc Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
NZ527990A (en) * 2001-02-27 2006-01-27 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neurodegenerative disorders
RU2303445C2 (ru) 2001-07-16 2007-07-27 Орто-Макнейл Фармасьютикал, Инк. Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
AU2005335241B9 (en) * 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
CN105164103B (zh) * 2013-03-12 2019-12-06 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
BR0207829A (pt) 2004-06-22
NZ527991A (en) 2005-04-29
TWI251486B (en) 2006-03-21
RU2302240C2 (ru) 2007-07-10
CZ20032297A3 (cs) 2004-06-16
RS51056B (sr) 2010-10-31
ES2275844T3 (es) 2007-06-16
CA2439480C (en) 2011-04-26
AR032876A1 (es) 2003-11-26
KR100886578B1 (ko) 2009-03-05
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
US20020165272A1 (en) 2002-11-07
DE60216457D1 (de) 2007-01-11
IL157588A (en) 2009-12-24
EP1401424A1 (en) 2004-03-31
PT1401424E (pt) 2007-02-28
US6541513B2 (en) 2003-04-01
NO20033801D0 (no) 2003-08-26
WO2002067927A1 (en) 2002-09-06
DE60216457T2 (de) 2007-09-20
CA2439480A1 (en) 2002-09-06
KR20030076713A (ko) 2003-09-26
MXPA03007722A (es) 2004-11-12
RU2003128983A (ru) 2005-03-10
PL365021A1 (en) 2004-12-27
HUP0303342A2 (hu) 2004-01-28
NO20033801L (no) 2003-10-22
ATE346597T1 (de) 2006-12-15
CN1262271C (zh) 2006-07-05
CN1505507A (zh) 2004-06-16
AU2002242296B2 (en) 2006-06-29
HUP0303342A3 (en) 2012-07-30
JP2004523556A (ja) 2004-08-05
RS67503A (en) 2006-12-15
CZ302412B6 (cs) 2011-05-04
IL157588A0 (en) 2004-03-28

Similar Documents

Publication Publication Date Title
DK1446122T5 (da) Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
DK1383489T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
DK2412368T3 (da) Sammensætning til behandling af ar
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1432701T3 (da) Heterocycliske forbindelser til anvendelse ved behandlingen af lidelser i urinvejene
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1401424T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
NO20033804L (no) Karbamatforbindelser for behandling av smerte
DK1245613T3 (da) Fremgangsmåde til fremstilling af tannin samt dets anvendelse
DK1268482T3 (da) Pyranoindoler til behandling af glaukom